15-Sept-2026 14:14:41
SUDARSHAN PHARMA: US STEP-DOWN SUBSIDIARY ACQUIRES 9.50% EQUITY SHARES OF MED THERAPY BIOTECHNOLOGY INC.
• Proposal to acquire 9.50% equity shares of Med Therapy Biotechnology Inc., USA is under due diligence. • Confirmation from Med Therapy Board of Directors dec…